高级搜索

GPDA 、CA72-4 、CA50 联检在胃癌诊断中的价值

The Value of Combined Detection of GPDA, CA7-24 and CA50 in Diagnosis of Gastric Cancer

  • 摘要: 目的 探讨GPDA、CA72-4、CA50三项联检对胃癌的临床诊断价值。方法 采用电化学发光免疫分析、放射免疫法及全自动生化分析仪等技术,对125例胃癌、77例胃良性疾病、50例正常健康人血清进行GPDA、CA72-4、CAS0三项检测。结果 胃癌组GPDA、CA72-4、CA50敏感性分别为62.4%、68.0%,54.4%;特异性分别为97.6%、97.6%、98.4%。三项联检敏感性提高到89.6%,与单检比较有统计学意义(P〈0.05);同时特异性并未明显降低,仍有93.7%。结论 GPDA、CA72-4、CA50可作为临床诊断胃癌的肿瘤标志物,三项联检可明显提高阳性检出率。

     

    Abstract: Objective  To study the diagnostic value of Glycyl Proline Dipeptidyl Aminopeptidase ( GPDA), CA7-24 and CA50 in gastric cancer. Methods  Serum levels of GPDA, CA7-24 and CA50 in 125 patients with gastric cancer, 77 patients with benign gastric tumor and 50 normal controls were measured by electro-chemiluminescence immuno-assay (ECLIA) and radioimmunoassay and automatic biochemical analyzer. Results  Sensitivities of GPDA, CA7-24 and CA50 in gastric cancer group were 62. 4 %, 68. 0 % and 54. 4 %, respectively, and the specificities were 97. 6 %, 97. 6 % and 98. 4 %, respectively. The sensitivity of combined detection of three tumor markers increased to 89. 6 %, and the specificity was 93. 7 %. Conclusion  GPDA, CA7-24 and CA50 can serve as the serum tumor marker in clinical diagnosis of gastric cancer. Combined detection of three kinds of serum tumor makers increases the detective positive rate.

     

/

返回文章
返回